These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8671606)

  • 21. Kinetics of MHC-antigen complex formation on antigen-presenting cells.
    Roosnek E; Demotz S; Corradin G; Lanzavecchia A
    J Immunol; 1988 Jun; 140(12):4079-82. PubMed ID: 2453565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.
    Ozaki S; Berzofsky JA
    J Immunol; 1987 Jun; 138(12):4133-42. PubMed ID: 2438335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical evidence for the rapid assembly and disassembly of processed antigen-major histocompatibility complex class II complexes in acidic vesicles of B cells.
    Marsh EW; Dalke DP; Pierce SK
    J Exp Med; 1992 Feb; 175(2):425-36. PubMed ID: 1310101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
    Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.
    Mills KH
    Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen.
    Accapezzato D; Nisini R; Paroli M; Bruno G; Bonino F; Houghton M; Barnaba V
    J Immunol; 1998 Jun; 160(11):5262-6. PubMed ID: 9605122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
    J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells.
    Bikoff EK; Eckhardt LA
    Eur J Immunol; 1989 Oct; 19(10):1903-9. PubMed ID: 2479567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones.
    Wyss-Coray T; Gallati H; Pracht I; Limat A; Mauri D; Frutig K; Pichler WJ
    Eur J Immunol; 1993 Dec; 23(12):3350-7. PubMed ID: 7504995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
    Wyss-Coray T; Brander C; Frutig K; Pichler WJ
    Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
    Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell recognition of endogenous IgG2a expressed in B lymphoma cells.
    Bikoff EK; Yu H; Eckhardt LA
    Eur J Immunol; 1988 Mar; 18(3):341-8. PubMed ID: 3258563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope-directed processing of specific antigen by B lymphocytes.
    Davidson HW; Watts C
    J Cell Biol; 1989 Jul; 109(1):85-92. PubMed ID: 2473083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerating antibody discovery using transgenic animals overexpressing the neonatal Fc receptor as a result of augmented humoral immunity.
    Cervenak J; Kurrle R; Kacskovics I
    Immunol Rev; 2015 Nov; 268(1):269-87. PubMed ID: 26497527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor-mediated signal transduction in transformed human T-cells.
    Arimilli S; Nag B
    Recept Signal Transduct; 1997; 7(3):151-63. PubMed ID: 9440502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.